Has Aerie Pharma Put The 'Binary Boogeyman' To Bed With Roclatan Phase 3 Data?
May 25, 2017 at 14:24 PM EDT
Aerie Pharmaceuticals Inc (NASDAQ: AERI) shares were seen up over 29 percent Thursday after the company reported positive Phase III ...
